CDC headquarters in Atlanta
Elijah Nouvelage | Bloomberg by way of Getty Pictures
A key U.S. Facilities for Illness Management and Prevention panel voted unanimously to suggest Pfizer-BioNTech’s Covid-19 vaccine for individuals 16 years and older on Saturday, clearing one other pivotal hurdle for the drug earlier than vaccinations start within the coming days.
The CDC’s Advisory Committee on Immunization Practices, an out of doors group of medical specialists that advises the company, voted 11 to 0 suggest the vaccine to be used in individuals 16 and older beneath the Meals and Drug Administrations emergency authorization. Three members recused themselves because of conflicts.
On Dec. 1, the group voted 13-1 to offer health-care staff and long-term care facility residents the primary vaccine doses as soon as cleared for public use. The ACIP’s emergency assembly, which was pushed from Sunday to Saturday, adopted the FDA’s choice to concern Pfizer’s vaccine an emergency use authorization Friday night.
It is a growing story. Please verify again later for updates.
